Company
Every investor coverage indicates participated in a round Summer Street Research Partners raised.
Companies Summer Street Research Partners acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Summer Street Research Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sunshine Heart has completed an A$9.5m rights issue, following a September placement of A$3.7m. Backers GBS Venture Partners and CM Capital took full entitlements plus shortfall; proceeds fund US trials and European approval.
Sunshine Heart has locked in A$3.7 million from US institutional investors via Summer Street, with a larger rights issue of up to A$11 million still planned pending shareholder backing at an October meeting.